The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tirabrutinib for the treatment of relapsed or refractory primary central nervous system lymphoma (R/R ...

Findings from the ASA International Stroke Conference show tenecteplase 4.5 to 24 hours after onset improves 90-day functional outcomes.

Higher consumption of caffeinated coffee and tea is associated with a reduced risk for dementia and improved cognitive function.

The ongoing measles outbreak across several US states has prompted an administration health official to advocate for the ...

Should we characterize Epstein-Barr virus (EBV) as a causative agent of multiple sclerosis (MS), or a risk factor for MS?” Micah Luftig, PhD: “I think we should characterize EBV as an essential ...

Treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I under review.

Long-term data suggest boosted cognitive speed training may reduce the risk for dementia diagnosis in adults aged 65 years and older.

Multiple sclerosis B-cell profiles differ by ancestry and sex among Black and Hispanic patients with multiple sclerosis.

Study data presented at ACTRIMS 2026 suggests clinical MS onset may precede laboratory-confirmed primary EBV infection in ...

Pregnancy and breastfeeding are associated with higher global cognition and better memory in postmenopausal women, per a new longitudinal study.

Higher prediagnostic intake of vitamin B6 and folate is associated with a reduced risk for all-cause mortality in patients with Parkinson disease.

The table below is a review of notable updates that occurred in January 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.